GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
|---|
| Intangible Asset, Goodwill and Other [Abstract] |
|
| Schedule of goodwill |
Goodwill as of June 30, 2026, 2025 and 2024 is presented below: | | | | | | | | | | | | | | | | | | | Prestige | | Consumer Beauty | | Total | | Gross balance at June 30, 2024 | $ | 6,214.6 | | | $ | 1,731.2 | | | $ | 7,945.8 | | | Accumulated impairments | (3,110.3) | | | (929.8) | | | (4,040.1) | | | Net balance at June 30, 2024 | $ | 3,104.3 | | | $ | 801.4 | | | $ | 3,905.7 | | | | | | | | | Changes during the year ended June 30, 2025 | | | | | | | | | | | | | Foreign currency translation | 125.5 | | | 31.0 | | | 156.5 | | | | | | | | | Gross balance at June 30, 2025 | $ | 6,340.1 | | | $ | 1,762.2 | | | $ | 8,102.3 | | | Accumulated impairments | (3,110.3) | | | (929.8) | | | (4,040.1) | | | Net balance at June 30, 2025 | $ | 3,229.8 | | | $ | 832.4 | | | $ | 4,062.2 | | | | | | | | | Changes during the year ended June 30, 2026 | | | | | | | Impairment Charges | — | | | (237.1) | | | (237.1) | | | Foreign currency translation | (14.4) | | | (1.0) | | | (15.4) | | | | | | | | | Gross balance at June 30, 2026 | 6,325.7 | | | 1,761.2 | | | 8,086.9 | | | Accumulated impairments | (3,110.3) | | | (1,166.9) | | | (4,277.2) | | | Net balance at June 30, 2026 | $ | 3,215.4 | | | $ | 594.3 | | | $ | 3,809.7 | |
|
| Schedule of indefinite-lived intangible assets |
Other intangible assets, net as of June 30, 2026 and 2025 are presented below: | | | | | | | | | | | | | June 30,
2026 | | June 30,
2025 | | Indefinite-lived other intangible assets | $ | 626.7 | | | $ | 761.0 | | | Finite-lived other intangible assets, net | 2,148.9 | | | 2,453.8 | | | Total Other intangible assets, net | $ | 2,775.6 | | | $ | 3,214.8 | |
The changes in the carrying amount of indefinite-lived other intangible assets are presented below: | | | | | | | | | | | | | Trademarks | | Total | | Gross balance at June 30, 2024 | $ | 1,889.5 | | | $ | 1,889.5 | | | Accumulated impairments | (944.9) | | | (944.9) | | | Net balance at June 30, 2024 | $ | 944.6 | | | $ | 944.6 | | | | | | | Changes during the year ended June 30, 2025 | | | | Impairment charges (a) | (212.8) | | | (212.8) | | | | | | | Foreign currency translation | 29.2 | | | 29.2 | | | | | | | Gross balance at June 30, 2025 | $ | 1,918.7 | | | $ | 1,918.7 | | | Accumulated impairments | (1,157.7) | | | (1,157.7) | | | Net balance at June 30, 2025 | $ | 761.0 | | | $ | 761.0 | | | | | | | Changes during the year ended June 30, 2026 | | | | Impairment charges | (125.7) | | | (125.7) | | | Foreign currency translation | (8.6) | | | (8.6) | | | | | | | Gross balance at June 30, 2026 | $ | 1,910.1 | | | $ | 1,910.1 | | Accumulated impairments | (1,283.4) | | | (1,283.4) | | | Net balance at June 30, 2026 | 626.7 | | | 626.7 | |
|
| Schedule of finite-lived intangible assets |
Intangible assets with finite lives are amortized principally using the straight-line method over the following estimated useful lives: | | | | | | | Description | Estimated Useful Lives | | License agreements | 2-34 years | | Customer relationships | 2-28 years | | Trademarks | 2-30 years | | Product formulations and technology | 2-28 years |
Other intangible assets, net as of June 30, 2026 and 2025 are presented below: | | | | | | | | | | | | | June 30,
2026 | | June 30,
2025 | | Indefinite-lived other intangible assets | $ | 626.7 | | | $ | 761.0 | | | Finite-lived other intangible assets, net | 2,148.9 | | | 2,453.8 | | | Total Other intangible assets, net | $ | 2,775.6 | | | $ | 3,214.8 | |
Intangible assets subject to amortization are presented below: | | | | | | | | | | | | | | | | | | | | | | | | | Cost | | Accumulated Amortization | | Accumulated Impairment | | Net | | June 30, 2025 | | | | | | | | License and collaboration agreements * | $ | 3,765.8 | | | $ | (1,614.9) | | | $ | (19.6) | | | $ | 2,131.3 | | | Customer relationships | 766.0 | | | (568.9) | | | (5.5) | | | 191.6 | | | Trademarks | 318.2 | | | (208.4) | | | (0.5) | | | 109.3 | | | Product formulations and technology | 87.8 | | | (66.2) | | | — | | | 21.6 | | | Total | $ | 4,937.8 | | | $ | (2,458.4) | | | $ | (25.6) | | | $ | 2,453.8 | | | June 30, 2026 | | | | | | | | | License and collaboration agreements | $ | 3,695.3 | | | $ | (1,817.7) | | | $ | (19.6) | | | $ | 1,858.0 | | | Customer relationships | 760.7 | | | (581.0) | | | (5.5) | | | 174.2 | | Trademarks | 316.0 | | | (218.7) | | | (0.5) | | | 96.8 | | | Product formulations and technology | 87.5 | | | (67.6) | | | — | | | 19.9 | | | Total | $ | 4,859.5 | | | $ | (2,685.0) | | | $ | (25.6) | | | $ | 2,148.9 | |
* On March 21, 2025, the KKW Collaboration Agreement was terminated pursuant to the KKW Sale Agreement. As such, the Company derecognized the remaining KKW Collaboration Agreement carrying amount of $142.5 as of the termination date.
|
| Schedule of finite-lived intangible assets weighted average remaining lives |
Intangible assets subject to amortization are amortized principally using the straight-line method and have the following weighted-average remaining lives: (1) | | | | | | | Description | | | License and collaboration agreements | 14.7 | | Customer relationships | 14.5 | | Trademarks | 13.4 | | Product formulations and technology | 18.3 |
|
| Schedule of finite-lived intangible assets, future amortization expense |
The estimated aggregate amortization expense for each of the following fiscal years ending June 30 is presented below: (1) | | | | | | | 2027 | $ | 125.7 | | | 2028 | 121.9 | | | 2029 | 119.6 | | | 2030 | 115.7 | | | 2031 | 115.1 | |
(1) The remaining weighted-average life of all intangible assets subject to amortization and the estimated aggregate amortization expense reflects the impact of the early termination of the Gucci License. Refer to Note 25 — Subsequent Events.
|